|
|
|
|
|
HOME >
CORPORATE INFO > BOARD MEETINGS
|
|
|
|
|
|
|
|
|
| Source Date | Board Meeting Date | Details |
|
24-Oct-2025
|
31-Oct-2025
|
Quarterly Results
|
|
30-Sep-2025
|
02-Oct-2025
|
Inter alia, to consider and approve and evaluate raising of funds through issue of equity securities and/or any other convertible or exchangeable securities, debt securities, warrants or any combination thereof, by way of a preferential offer, a private placement, rights offering, qualified institutions placement or a combination thereof, or such other methods or combinations as may be considered appropriate, subject to the approval of the members of the Company and regulatory and/or statutory approvals, as applicable.
|
|
01-Sep-2025
|
03-Sep-2025
|
Inter alia, to consider and approve:- (a) raising of funds through the issuance of any kind(s) of debt securities, in one or more tranches, whether domestic or international, as may be considered appropriate, subject to the regulatory and/or statutory approvals, as applicable; (b) convening 20th Annual General Meeting of the Company (20th AGM); (c) shareholders? approval, for renewal of annual authorization for issuance of secured and/or unsecured NCDs/Bonds, in one or more tranches, on private placement basis, in 20th AGM; and (d) payment of dividend, if any, on the equity shares of the Company, for the financial year 2024-25.
|
|
08-Aug-2025
|
13-Aug-2025
|
Quarterly Results
|
|
12-May-2025
|
16-May-2025
|
Audited Results
|
|
04-Feb-2025
|
11-Feb-2025
|
Quarterly Results
|
|
09-Dec-2024
|
11-Dec-2024
|
Inter alia, to consider and approve:- (1) raising of funds through issue of secured and/or unsecured debt and/or equity securities and/or any other convertible or exchangeable securities, including but not limited to, FCCBs, FCEBs or any combination thereof, by way of a public or preferential offer, a private placement, follow-on public offering, rights offering, qualified institutions placement or a combination thereof, or such other methods or combinations as may be decided, in India or abroad, and pricing thereof, as may be considered appropriate, subject to the approval of the members of the Company, and other regulatory and/or statutory approvals, as applicable.
|
|
11-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
|
26-Aug-2024
|
29-Aug-2024
|
Inter alia, to consider and approve:- (1) for convening 19th Annual General Meeting of the Company (19th AGM) and considering seeking shareholders? approval, for renewal of annual authorization for issuance of secured and/or unsecured NCDs/Bonds, in one or more tranches, on private placement basis, in 19th AGM.
|
|
05-Aug-2024
|
13-Aug-2024
|
Quarterly Results
|
|
17-May-2024
|
24-May-2024
|
Dividend & Audited Results
|
|
13-Mar-2024
|
15-Mar-2024
|
Inter alia, to consider the raising of funds through the issuance of any kind(s) of debt securities, in one or more tranches, whether domestic or international, as may be considered appropriate, subject to the regulatory and/or statutory approvals, as applicable
|
|
06-Feb-2024
|
14-Feb-2024
|
Quarterly Results
|
|
24-Jan-2024
|
28-Jan-2024
|
Right Issue of Equity Shares (Revised)
|
|
20-Jan-2024
|
24-Jan-2024
|
Right Issue of Equity Shares
|
|
15-Jan-2024
|
17-Jan-2024
|
Inter alia, to consider and approve: Raising of funds through issue of secured and/or unsecured debt and/or equity shares and/or any other convertible or exchangeable securities, including but not limited to, warrants, depository receipts, FCCBs, FCEBs or any combination thereof, by way of a public or preferential offer, a private placement, follow-on public offering, rights issue, qualified institutions placement or a combination thereof, or such other methods or combinations as may be decided, in India or abroad, as may be considered appropriate, subject to the regulatory and/or statutory approvals, as applicable.
|
|
07-Nov-2023
|
14-Nov-2023
|
Quarterly Results
|
|
07-Aug-2023
|
14-Aug-2023
|
Quarterly Results
|
|
25-Jul-2023
|
28-Jul-2023
|
Final Dividend & Inter alia, to consider and approve:- (a) issuance of secured and/or unsecured NCDs/Bonds, in one or more tranches, on private placement basis, and (b) declaration of final dividend, if any, on the Equity shares of the Company, for the financial year 2022-23.
|
|
15-May-2023
|
22-May-2023
|
Audited Results
|
|
|
|
|
|
|
|
|
|